Home
How we impact
Our clients
Team
Featured
Contact
- Contact
- Directions

Home
How we impact
Our clients
Team
Featured
Contact
- Contact
- Directions

Forbion in zee met rijke families om nieuwe medicijnen te ontwikkelen

Forbion in zee met rijke families om nieuwe medicijnen te ontwikkelen

Forbion in zee met rijke families om nieuwe medicijnen te ontwikkelen

Twelve Capital issues the private Catastrophe Bond “Dodeka IV”
Clear Path Analysis White Paper

Posted on June 3, 2014 in Forbion highlight

Article in the “Financieel Dagblad” Friday 23 May 2014. Click here to read.

Tags:Financieel Dagblad, Forbion, Venture Capital

Related Articles

Forbion Portfolio Company, AM-Pharma raises €116m
Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk
Forbion Appoints Dr. Carlo Incerti as Operating Partner
Forbion Co-leads $54m Series A Financing in newly formed Gotham Therapeutics

Search

Search for:

Partner Categories

747 Capital
BioGeneration Ventures
Forbion
Incofin
TrueBridge
Twelve

Recent Features

Closed Loop Partners Invests Nearly $15M in Recycling Infrastructure Upgrades Across Several U.S. Municipalities
Closed Loop Partners Acquires Majority Stake in Sage Sustainable Electronics, Accelerating IT Asset Management and Disposition Services in North America
Osmosis wins €4.2bn ESG mandate from giant Dutch pension fund
The Circular Economy: what is it?
Closed Loop Partners Provides New Funding for Midwest Recycling Program

XS Investments offer investment products and services to professional investors only.
XS Investments BV is licensed by the AFM and under supervision of AFM and DNB. Disclaimer.
©2024 XS Investments. All rights reserved.